BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Hayley Waterman
Press Release

IgA Autoantibodies Synergize With IgG To Increase Inflammatory Responses in Lupus

Read More
Peter Linsley
Press Release

New Study in Nature Communications From Benaroya Research Institute Finds Islet Antigen Reactive TCR Alpha Chains are Shared Between Blood and Pancreas T Cells

Read More
John Ray
External News

BRI’s John Ray, PhD, Receives Lupus Research Alliance Lupus Innovation Award

Read More ➡
Christine Bender
Press Release

A Subset of Expanded Regulatory T Cells Is Linked With C-Peptide Preservation in Children With New Onset Type 1 Diabetes

Read More
Sheenam Verma
Press Release

A Novel Approach To Identify and Investigate B Cells Specific to Gut Microbes

Read More
Blog Main Image - BRI Building Rear
Press Release

Benaroya Research Institute Awarded $4.1 Million National Institutes of Health Grant to Study Regulatory T Cells’ Function in Immune System Homeostasis

Read More
Blog Main Gretchen Schoenstein R&R 2024 Editorial
Press Release

Runner Completes “2 Half Marathons, 2 Coasts, 2 Days” in support of BRI and Autoimmune Disease Awareness

Read More
News Science in Seattle
External News

LITAF Protects Against Pore-Forming Protein–Induced Cell Death by Promoting Membrane Repair: Interview with Drs. Stefani & Lacy-Hulbert

Read More ➡
News American Association of Immunologists AAI
Press Release

Benaroya Research Institute’s Steven F. Ziegler, PhD, Named 2024 Distinguished Fellow by the American Association of Immunologists

Read More
News American Association of Immunologists AAI
Press Release

Benaroya Research Institute President Jane Buckner, MD, Receives 2024 American Association of Immunologists’ Steinman Award for Human Immunology Research

Read More
LITAF Cd63 DNA
Press Release

Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death

Read More
News Science in Seattle
External News

Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab

Read the publication ➡
News Main Image - Puget Sound Business Journal
Press Release

Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award

Read More
News Immunology Podcast
News

BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast

Read More
News NIH New Innovator
Press Release

Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award

Read More